66 related articles for article (PubMed ID: 32530018)
1. Amphiphilic drug-peptide-polymer conjugates based on poly(ethylene glycol) and hyperbranched polyglycerol for epidermal growth factor receptor targeting: the effect of conjugate aggregation on in vitro activity.
Pethő L; Kasza G; Lajkó E; Láng O; Kőhidai L; Iván B; Mező G
Soft Matter; 2020 Jun; 16(24):5759-5769. PubMed ID: 32530018
[TBL] [Abstract][Full Text] [Related]
2. NGR-peptide-drug conjugates with dual targeting properties.
Enyedi KN; Tóth S; Szakács G; Mező G
PLoS One; 2017; 12(6):e0178632. PubMed ID: 28575020
[TBL] [Abstract][Full Text] [Related]
3. Poly(Ethylene glycol)-based backbones with high peptide loading capacities.
O'Connor A; Marsat JN; Mitrugno A; Flahive T; Moran N; Brayden D; Devocelle M
Molecules; 2014 Oct; 19(11):17559-77. PubMed ID: 25361422
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of the cell and molecular biological effect of peptide-based daunorubicin conjugates developed for targeting pancreatic adenocarcinoma (PANC-1) cell line.
Szász Z; Enyedi KN; Takács A; Fekete N; Mező G; Kőhidai L; Lajkó E
Biomed Pharmacother; 2024 Apr; 173():116293. PubMed ID: 38430628
[TBL] [Abstract][Full Text] [Related]
5. PEGylation of a Peptide-Based Amphiphilic Delivery Agent and Influence on Protein Delivery to Cells.
Greschner AA; Brahiti N; Auger M; Hu L; Soleymani Abyaneh H; Barbeau X; Parent V; Gaillet B; Guay D; Soultan AH; Gauthier MA
Biomacromolecules; 2023 Nov; 24(11):4890-4900. PubMed ID: 37862236
[TBL] [Abstract][Full Text] [Related]
6. Protein-Polymer Conjugates Synthesized Using Water-Soluble Azlactone-Functionalized Polymers Enable Receptor-Specific Cellular Uptake toward Targeted Drug Delivery.
Kim JS; Sirois AR; Vazquez Cegla AJ; Jumai'an E; Murata N; Buck ME; Moore SJ
Bioconjug Chem; 2019 Apr; 30(4):1220-1231. PubMed ID: 30920802
[TBL] [Abstract][Full Text] [Related]
7. New design of helix bundle peptide-polymer conjugates.
Shu JY; Tan C; DeGrado WF; Xu T
Biomacromolecules; 2008 Aug; 9(8):2111-7. PubMed ID: 18627200
[TBL] [Abstract][Full Text] [Related]
8. Polymer Cancerostatics Containing Cell-Penetrating Peptides: Internalization Efficacy Depends on Peptide Type and Spacer Length.
Böhmová E; Pola R; Pechar M; Parnica J; Machová D; Janoušková O; Etrych T
Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31936737
[TBL] [Abstract][Full Text] [Related]
9. Targeting of the epidermal growth factor receptor with mesoporphyrin IX-peptide conjugates.
Fontenot KR; Ongarora BG; LeBlanc LE; Zhou Z; Jois SD; Vicente MG
J Porphyr Phthalocyanines; 2016 Jan; 20(1-4):352-366. PubMed ID: 27738394
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial Peptide-Poly(ethylene glycol) Conjugates: Connecting Molecular Architecture, Solution Properties, and Functional Performance.
Cui Z; Crawford MA; Rumble BA; Krogh MM; Hughes MA; Letteri RA
ACS Polym Au; 2024 Feb; 4(1):45-55. PubMed ID: 38371733
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Cyclic and Linear PEG Conjugates.
Kunkel GE; Zhou Q; Treacy JW; Montgomery HR; Salas-Ambrosio P; Ready AD; Spokoyny AM; Houk KN; Maynard HD
Bioconjug Chem; 2024 Jun; 35(6):744-749. PubMed ID: 38809040
[TBL] [Abstract][Full Text] [Related]
12. In situ growth of a stoichiometric PEG-like conjugate at a protein's N-terminus with significantly improved pharmacokinetics.
Gao W; Liu W; Mackay JA; Zalutsky MR; Toone EJ; Chilkoti A
Proc Natl Acad Sci U S A; 2009 Sep; 106(36):15231-6. PubMed ID: 19706892
[TBL] [Abstract][Full Text] [Related]
13. Podophyllotoxin-loaded PEGylated E-selectin peptide conjugate targeted cancer site to enhance tumor inhibition and reduce side effect.
Xiang C; Fu Y; Hao T; Wei L; Liu Y; Fan ZC; Guo N; Yu P; Teng YO
Eur J Med Chem; 2023 Nov; 260():115780. PubMed ID: 37666045
[TBL] [Abstract][Full Text] [Related]
14. Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview.
Mező G; Gomena J; Ranđelović I; Dókus EL; Kiss K; Pethő L; Schuster S; Vári B; Vári-Mező D; Lajkó E; Polgár L; Kőhidai L; Tóvári J; Szabó I
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339141
[TBL] [Abstract][Full Text] [Related]
15. Innovative Design of Targeted Nanoparticles: Polymer-Drug Conjugates for Enhanced Cancer Therapy.
Junyaprasert VB; Thummarati P
Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765185
[TBL] [Abstract][Full Text] [Related]
16. Modular design of cyclic peptide - polymer conjugate nanotubes for delivery and tunable release of anti-cancer drug compounds.
Hill SK; England RM; Perrier S
J Control Release; 2024 Mar; 367():687-696. PubMed ID: 38262487
[TBL] [Abstract][Full Text] [Related]
17. Effect of Polymer Hydrophilicity and Molar Mass on the Properties of the Protein in Protein-Polymer Conjugates: The Case of PPEylated Myoglobin.
Pelosi C; Duce C; Wurm FR; Tinè MR
Biomacromolecules; 2021 May; 22(5):1932-1943. PubMed ID: 33830737
[TBL] [Abstract][Full Text] [Related]
18. Polymer Structure and Conformation Alter the Antigenicity of Virus-like Particle-Polymer Conjugates.
Lee PW; Isarov SA; Wallat JD; Molugu SK; Shukla S; Sun JE; Zhang J; Zheng Y; Lucius Dougherty M; Konkolewicz D; Stewart PL; Steinmetz NF; Hore MJ; Pokorski JK
J Am Chem Soc; 2017 Mar; 139(9):3312-3315. PubMed ID: 28121424
[TBL] [Abstract][Full Text] [Related]
19. Tuning Polymer Composition Leads to Activity-Stability Tradeoff in Enzyme-Polymer Conjugates.
Bisirri EA; Wright TA; Schwartz DK; Kaar JL
Biomacromolecules; 2023 Sep; 24(9):4033-4041. PubMed ID: 37610792
[TBL] [Abstract][Full Text] [Related]
20. GE11 Peptide as an Active Targeting Agent in Antitumor Therapy: A Minireview.
Genta I; Chiesa E; Colzani B; Modena T; Conti B; Dorati R
Pharmaceutics; 2017 Dec; 10(1):. PubMed ID: 29271876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
